Basic Information
| RNALocate ID: | RLID:11004373 |
| RNA Symbol: | hsa-miR-320d |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-320d |
| RNA ID: | miRBase:MIMAT0006764 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25330373 |
| Tissue/Cell Line: | Colon cancer cell line (LIM1863) |
| Method: | qRT-PCR|RNA sequencing |
| Description: | To assess whether some miRNAs are specifically sorted into EVs we conducted a miRNA-enrichment analysis for A33-Exos, EpCAM-Exos and sMVs. MiRNAs with <2 fold changes relative to CL miRNAs were filtered out, yielding 63 miRNAs for comparison (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002800 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11004369 | Exosome | Pooled sera | 27278097 |
| RLID:11004370 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11004371 | Exosome | Plasma | 23663360 |
| RLID:11004372 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11004374 | Microvesicle | Plasma | 23077538 |
| RLID:11004375 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000804 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001744 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-320d | Ovarian clear cell carcinoma | MNDR-E-MI-39497 |
| MNDR | hsa-miR-320d | Estrogen-receptor positive breast cancer | MNDR-E-MI-39498 |
| MNDR | hsa-miR-320d | Estrogen-receptor negative breast cancer | MNDR-E-MI-39499 |
| MNDR | hsa-miR-320d | Progesterone-receptor positive breast cancer | MNDR-E-MI-39500 |
| MNDR | hsa-miR-320d | Progesterone-receptor negative breast cancer | MNDR-E-MI-39501 |
| MNDR | hsa-miR-320d | Her2-receptor positive breast cancer | MNDR-E-MI-39502 |
| MNDR | hsa-miR-320d | Prostate cancer | MNDR-E-MI-39503 |
| MNDR | hsa-miR-320d | Gastric cancer | MNDR-E-MI-39504 |
| MNDR | hsa-miR-320d | Alzheimer disease | MNDR-E-MI-39505 |
| MNDR | hsa-miR-320d | Intracranial aneurysm | MNDR-E-MI-39506 |
| MNDR | hsa-miR-320d | Cardiovascular disease | MNDR-E-MI-39507 |
| MNDR | hsa-miR-320d | Moyamoya disease | MNDR-E-MI-39508 |
| MNDR | hsa-miR-320d | Lung cancer | MNDR-E-MI-39509 |
| MNDR | hsa-miR-320d | Parkinson disease | MNDR-E-MI-39510 |
| MNDR | hsa-miR-320d | Breast cancer | MNDR-E-MI-39511 |
| MNDR | hsa-miR-320d | Pancreatic cancer | MNDR-E-MI-39512 |
| MNDR | hsa-miR-320d | Nephroblastoma | MNDR-E-MI-39513 |
| MNDR | hsa-miR-320d | Colon cancer | MNDR-E-MI-39514 |
| MNDR | hsa-miR-320d | Relapsing-remitting multiple sclerosis | MNDR-E-MI-39515 |
| MNDR | hsa-miR-320d | Familial ovarian cancer | MNDR-E-MI-39516 |
| MNDR | hsa-miR-320d | Prostate adenocarcinoma | MNDR-E-MI-39517 |
| MNDR | hsa-miR-320d | Carcinoma ductal breast | MNDR-E-MI-39518 |
| MNDR | hsa-miR-320d | Glioblastoma | MNDR-E-MI-39519 |
| MNDR | hsa-mir-320d | Glioma | MNDR-E-MI-39520 |
| MNDR | hsa-miR-320d | Chronic obstructive pulmonary disease | MNDR-E-MI-39521 |
| MNDR | hsa-miR-320d | Chordoma | MNDR-E-MI-39522 |
| MNDR | hsa-miR-320d | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39523 |
| MNDR | hsa-miR-320d | Lung squamous cell carcinoma | MNDR-E-MI-39524 |
| MNDR | hsa-miR-320d | Non-small cell lung adenocarcinoma | MNDR-E-MI-39525 |
| MNDR | hsa-miR-320d | Lung adenocarcinoma | MNDR-E-MI-39526 |
| MNDR | hsa-miR-320d | Adrenocortical cancer | MNDR-E-MI-39527 |
| MNDR | hsa-miR-320d | Thyroid carcinoma | MNDR-E-MI-39528 |
| MNDR | hsa-miR-320d | Pancreatic adenocarcinoma | MNDR-E-MI-39529 |
| MNDR | hsa-miR-320d | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39530 |
| MNDR | hsa-miR-320d | Kidney renal clear cell carcinoma | MNDR-E-MI-39531 |
| MNDR | hsa-miR-320d | Renal clear cell carcinoma | MNDR-E-MI-39532 |
| MNDR | hsa-miR-320d | Biliary tract cancer | MNDR-E-MI-39533 |
| MNDR | hsa-miR-320d | Head and neck squamous cell carcinoma | MNDR-E-MI-39534 |
| MNDR | hsa-miR-320d | Breast invasive carcinoma | MNDR-E-MI-39535 |
| MNDR | hsa-miR-320d | Familiar ovarian carcinoma | MNDR-E-MI-39536 |
| MNDR | hsa-miR-320d | B-cell lymphoma | MNDR-E-MI-39537 |
| MNDR | hsa-miR-320d | Rheumatoid arthritis | MNDR-E-MI-39538 |
| MNDR | hsa-miR-320d | Retinoblastoma | MNDR-E-MI-39539 |
| MNDR | hsa-miR-320d | Skin cutaneous melanoma | MNDR-E-MI-39540 |
| MNDR | hsa-miR-320d | Skin melanoma | MNDR-E-MI-39541 |
| MNDR | hsa-miR-320d | Colorectal cancer | MNDR-E-MI-39542 |
| MNDR | hsa-miR-320d | Stroke lacunar | MNDR-E-MI-39543 |
| MNDR | hsa-miR-320d | Breast cancer her3+ negative | MNDR-E-MI-39544 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABHD13 | Homo sapiens | RR00025355 |
TOP